Theralia AB

Theralia AB is a pioneering biotech company dedicated to revolutionizing how nucleoside analogues are employed in diverse therapeutic landscapes. Innovative Drug Delivery through TOUCAN: A New Horizon TOUCAN, our groundbreaking drug delivery technology, paves the way for a new era of medical intervention. We are overcoming the limitations posed by conventional systemic and naked delivery approaches, often fraught with the specter of high toxicity and suboptimal treatment outcomes. Our Mission: Safety, Efficacy, and Accessibility At the heart of our mission lies a resolute commitment to refining the safety and efficacy of nucleoside analogues and other drugs. Our aim is to enhance the safety profile and efficacy of existing therapeutic drugs, making them accessible to a broader patient population and improving treatment outcomes.